Long-term effects of bone marrow transplantation

J E Sanders1

  • 1Fred Hutchinson Cancer Research Center, Children's Hospital and Medical Center, Seattle, Wash.

Pediatrician
|January 1, 1991
PubMed

Insights

Children surviving marrow transplants face delayed effects from the procedure, original disease, and treatment. Awareness of these issues, including graft-versus-host disease and secondary cancers, is crucial for improving long-term quality of life.

Area of Science:

  • Pediatric Hematology/Oncology
  • Transplantation Medicine
  • Long-term Survivorship

Background:

  • Increasing numbers of children are surviving longer after marrow transplantation.
  • Delayed adverse effects are becoming more apparent in pediatric survivors.

Purpose of the Study:

  • To identify and describe the spectrum of late effects following pediatric marrow transplantation.
  • To emphasize the need for awareness to improve long-term outcomes.

Main Methods:

  • Review of known late effects in pediatric marrow transplant survivors.
  • Categorization of effects based on origin: transplant procedure, original disease, or preparative regimen.

Main Results:

  • Late effects include engraftment instability, chronic graft-versus-host disease, and delayed immune recovery.
  • Recurrent disease is a major concern related to the original illness.
  • Therapy-related effects encompass neuroendocrine, ocular, dental, CNS dysfunction, and secondary malignancies.

Conclusions:

  • Delayed effects significantly impact pediatric marrow transplant survivors' quality of life.
  • Understanding these late complications is essential for proactive management and prevention of growth/developmental abnormalities.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...